These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 6230270

  • 41. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave JP, Mannucci PM.
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [Abstract] [Full Text] [Related]

  • 42. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N, Fukuda N, Tremblay J, Hamet P.
    J Cardiovasc Pharmacol; 1993 May; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [Abstract] [Full Text] [Related]

  • 43. Mechanism of platelet aggregation and release: their possible role in vascular injury.
    Ardlie NG.
    Perspect Nephrol Hypertens; 1973 May; 1 Pt 2(0):891-905. PubMed ID: 4610504
    [No Abstract] [Full Text] [Related]

  • 44. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV, Rogers RC, Loadholt CB, Colwell JA.
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [Abstract] [Full Text] [Related]

  • 45. [Blood platelet functional state and exposure to an aggregation inducer].
    Markosian RA, Popov EG, Radin AIu, Gabbasov ZA.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981 Jan; 4(2):47-51. PubMed ID: 7317159
    [Abstract] [Full Text] [Related]

  • 46. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT, Tayebjee MH, Lim HS, Lip GY.
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [Abstract] [Full Text] [Related]

  • 47. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G, Sinzinger H, Silberbauer K, Freyler H, Mühlhauser I, Kaliman J.
    Horm Metab Res Suppl; 1981 Dec; 11():33-43. PubMed ID: 6459282
    [No Abstract] [Full Text] [Related]

  • 48. Factors contributing to platelet hyperactivity in diabetes mellitus.
    Dupuy E, Guillausseau PJ.
    Adv Exp Med Biol; 1984 Dec; 164():105-10. PubMed ID: 6229977
    [No Abstract] [Full Text] [Related]

  • 49. Influence of metabolic control on platelet functions in diabetic mellitus.
    Janka HU, Demmel P.
    Horm Metab Res Suppl; 1981 Dec; 11():29-33. PubMed ID: 6274778
    [Abstract] [Full Text] [Related]

  • 50. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage.
    Janka HU, Standl E, Schramm W, Mehnert H.
    Diabetes; 1983 May; 32 Suppl 2():47-51. PubMed ID: 6086025
    [Abstract] [Full Text] [Related]

  • 51. Maintenance of platelet viability after platelet-labeling with fluorescein isothiocyanate.
    Klaverkamp J, Völkl KP.
    Haemostasis; 1984 May; 14(4):337-46. PubMed ID: 6238881
    [Abstract] [Full Text] [Related]

  • 52. Platelet half-life in comparison to other in-vivo platelet function parameters such as thromboxane B2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemia.
    Strobl-Jäger E, Fitscha P, Kaliman J, Widhalm K, Sinzinger H.
    Vasa; 1986 May; 15(4):373-8. PubMed ID: 2948337
    [No Abstract] [Full Text] [Related]

  • 53. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J, Umeda F, Wakasugi H, Ibayashi H.
    Thromb Haemost; 1984 Jul 29; 51(3):313-6. PubMed ID: 6495252
    [Abstract] [Full Text] [Related]

  • 54. Platelet abnormalities as related to diabetic retinopathy (with special reference to platelet shape change).
    Porta M, O'Brien ME, Kohner EM.
    Horm Metab Res Suppl; 1981 Jul 29; 11():50-4. PubMed ID: 6797912
    [Abstract] [Full Text] [Related]

  • 55. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF, Elghoroury EA, Helmy A.
    Blood Coagul Fibrinolysis; 2009 Jun 29; 20(4):230-9. PubMed ID: 19521197
    [Abstract] [Full Text] [Related]

  • 56. Platelet function and thrombus in diabetes.
    Viinikka L.
    Acta Endocrinol Suppl (Copenh); 1985 Jun 29; 272():31-4. PubMed ID: 3914801
    [Abstract] [Full Text] [Related]

  • 57. [Determination of the level of plasma beta-thromboglobulin in diabetes].
    Stoltz JF, Voisin P, Drouin P, Pointel JP, Benisti G.
    Biomedicine; 1980 Jun 29; 33(6):194-6. PubMed ID: 6163487
    [Abstract] [Full Text] [Related]

  • 58. The role of platelets in the development and complications of atherosclerosis.
    Packham MA, Mustard JF.
    Semin Hematol; 1986 Jan 29; 23(1):8-26. PubMed ID: 3511536
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.